Treatment of COVID-19 disease in pregnancy and breastfeeding
The physiological and anatomical clinical characteristics of pregnant women make them susceptible to complications caused by coronavirus disease (COVID-19). Increased coagulation and risk of thromboembolic phenomena are common during pregnancy; they are further enhanced when associated with a thrombogenic pathology such as in COVID-19. The treatment of COVID-19 is controversial and limited, even for non-pregnant patients. During pregnancy, the options are even more restricted due to the teratogenicity of some drugs and anatomical and physiological difficulties, especially in advanced pregnancy in patients with respiratory failure. Therefore, the focus of treatment for pregnant patients should be centered on isolation, monitoring fetal and maternal vital signs, uterine activity, and general maternal-fetal well-being. The prescription of drugs and management orientation should be based on gestational age and maternal clinical conditions. The optimal type of delivery is guided by obstetric indications and COVID-19 disease severity. Breastfeeding should be encouraged with the use of masks and hand hygiene. The treatment of pregnant women with COVID-19 brings important peculiarities that should be considered in order to make better decisions for preserving the health of the mother and fetus..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Сеченовский вестник - 12(2021), 2, Seite 44-54 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
S. S. Rios [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Anticoagulation |
|---|
| doi: |
10.47093/2218-7332.2021.12.2.44-54 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ034942785 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ034942785 | ||
| 003 | DE-627 | ||
| 005 | 20230410115833.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2021 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.47093/2218-7332.2021.12.2.44-54 |2 doi | |
| 035 | |a (DE-627)DOAJ034942785 | ||
| 035 | |a (DE-599)DOAJd220352473e24c118e42104bf6dd7525 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a S. S. Rios |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment of COVID-19 disease in pregnancy and breastfeeding |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The physiological and anatomical clinical characteristics of pregnant women make them susceptible to complications caused by coronavirus disease (COVID-19). Increased coagulation and risk of thromboembolic phenomena are common during pregnancy; they are further enhanced when associated with a thrombogenic pathology such as in COVID-19. The treatment of COVID-19 is controversial and limited, even for non-pregnant patients. During pregnancy, the options are even more restricted due to the teratogenicity of some drugs and anatomical and physiological difficulties, especially in advanced pregnancy in patients with respiratory failure. Therefore, the focus of treatment for pregnant patients should be centered on isolation, monitoring fetal and maternal vital signs, uterine activity, and general maternal-fetal well-being. The prescription of drugs and management orientation should be based on gestational age and maternal clinical conditions. The optimal type of delivery is guided by obstetric indications and COVID-19 disease severity. Breastfeeding should be encouraged with the use of masks and hand hygiene. The treatment of pregnant women with COVID-19 brings important peculiarities that should be considered in order to make better decisions for preserving the health of the mother and fetus. | ||
| 650 | 4 | |a antivirals | |
| 650 | 4 | |a corticosteroids | |
| 650 | 4 | |a anticoagulation | |
| 650 | 4 | |a enoxaparin | |
| 650 | 4 | |a oxygen supplementation | |
| 650 | 4 | |a labor management | |
| 653 | 0 | |a Medicine (General) | |
| 700 | 0 | |a C. N. Resende |e verfasserin |4 aut | |
| 700 | 0 | |a A. B. Peixoto |e verfasserin |4 aut | |
| 700 | 0 | |a E. Araujo Junior |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Сеченовский вестник |d Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 2021 |g 12(2021), 2, Seite 44-54 |w (DE-627)DOAJ078607779 |x 26583348 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2021 |g number:2 |g pages:44-54 |
| 856 | 4 | 0 | |u https://doi.org/10.47093/2218-7332.2021.12.2.44-54 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/d220352473e24c118e42104bf6dd7525 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.sechenovmedj.com/jour/article/view/391 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2218-7332 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2658-3348 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2021 |e 2 |h 44-54 | ||